Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model

BACKGROUND: Dysregulation of the Src pathway has been shown to be important at various stages of cancer. Dasatinib is a potent Src/Abl inhibitor and has demonstrated to have anti-proliferative and anti-invasive activity in many preclinical models. The objective of this study was to determine the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Aaron J., Song, Eun-Kee, Bagby, Stacey, Purkey, Alicia, McCarter, Martin, Gajdos, Csaba, Quackenbush, Kevin S., Cross, Benjamin, Pitts, Todd M., Tan, Aik Choon, Eckhardt, S. Gail, Fenton, Hubert, Arcaroli, John, Messersmith, Wells A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665512/
https://www.ncbi.nlm.nih.gov/pubmed/29091939
http://dx.doi.org/10.1371/journal.pone.0187173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665512/
https://www.ncbi.nlm.nih.gov/pubmed/29091939
http://dx.doi.org/10.1371/journal.pone.0187173

Ejemplares similares